KEFEA: Vote on NHS law is important

Paves the way to improve patients’ access to innovative medicines The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) welcomes the vote on the NHS bill by the House of Representatives Plenum. This is an important moment for the Republic...

KEFEA: New medicine being victimised

Pharmaceutical companies say they are trapped because they cannot delete products from the price list There will be problems in the unimpeded distribution of medicines in the Cyprus market, particularly the availability of new, innovative treatments following the...

EFPIA Director General in Cyprus

He will discuss the NHS with the Finance and Health Ministers The implementation of the National Health System (NHS), as well as Cypriot patients’ access to innovative medicines, will be discussed during separate meetings between the Director General of the European...